Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJudith M. Rollinger
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The Protein Data Bank
10.1093/nar/28.1.235 · 2000
Rediscovering the sweet spot in drug discovery
10.1016/s1359-6446(03)02902-7 · 2003
Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of ɛ-viniferin
10.2174/1570163054866873 · 2005
Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin
10.1055/s-2007-990216 · 2007
The impact of pharmacophore modeling in drug design
2005
Strategies for discovering drugs from previously unexplored natural products
10.1016/s1359-6446(00)01511-7 · 2000
Network pharmacology: the next paradigm in drug discovery
10.1038/nchembio.118 · 2008
DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0
10.1186/1752-153x-2-18 · 2008
Pharmacophore modeling in drug discovery and development: an overview
10.2174/157340607780059521 · 2007
The Protein Data Bank (PDB), its related services and software tools as key components for in-silico guided drug discovery
10.1021/jm8005977 · 2008
Virtual ligand screening: strategies, perspectives and limitations
10.1016/j.drudis.2006.05.012 · 2006
Can the pharmaceutical industry reduce attrition rates?
10.1038/nrd1470 · 2004
How to design multi-target drugs: target search options in cellular networks
10.1517/17460441.2.6.799 · 2007
Recent advances in docking and scoring
10.2174/1573409052952314 · 2005
Pharmacophore modelling: applications in drug discovery
10.1517/17460441.1.3.261 · 2006
Pharmacophore modeling and parallel screening for PPAR ligands
10.1007/s10822-007-9140-0 · 2007
Natural products as sources of new drugs over the last 25 years
10.1021/np068054v · 2007
Recovering the true targets of specific ligands by virtual screening of the Protein Data Bank
10.1002/prot.10625 · 2004
In silico screening of the protein structure repertoire and of protein families
10.1142/9781860948114_0005 · 2006
Strategies for efficient lead structure discovery from natural products
10.2174/092986706777442075 · 2006
Integrated in silico tools to exploit the natural products’ bioactivity
10.1055/s-2006-941506 · 2006
Virtual screening for the discovery of bioactive natural products
2008
Unresolved referenced work
Kept as external metadata until matched
Virtual screening and fast automated docking methods
10.1016/s1359-6446(01)02091-8 · 2002
Ligand discovery on massively parallel systems
10.1147/rd.521.0057 · 2008
Lead discovery using molecular docking
10.1016/s1367-5931(02)00339-3 · 2002
Parallel screening: a novel concept in pharmacophore modelling and virtual screening
10.1021/ci6002043 · 2006
High throughput structure-based pharmacophore modeling as a basis for successful parallel virtual screening
10.1007/s10822-006-9066-y · 2006
Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models
10.1021/ci600321m · 2007
The role of natural products in a modern drug discovery program
10.1016/s1359-6446(99)01443-9 · 2000
Ligand discovery and virtual screening using the program LIDAEUS
10.1038/sj.bjp.0707532 · 2008
Why are secondary metabolites (natural products) synthesized?
10.1021/np50066a001 · 1989
LigandScout: 3D pharmacophores derived from protein-bound ligands and their use as virtual screening filters
10.1021/ci049885e · 2005
DOVIS: an implementation for high-throughput virtual screening using AutoDock
10.1186/1471-2105-9-126 · 2008
No additional external references are available.